Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations

Journal of Cellular Physiology

Volumn 223, Issue 2, 2010, Pages 530-540

  Psaltis, P J ^a,b,c   Paton, S ^a,b   See, F ^d,e   Arthur, A ^a,b   Martin, S ^b   Itescu, S ^d,e   Worthley, S G ^a,c   Gronthos, S ^a,b   Zannettino, A C W ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SCATTER FACTOR; STROMAL CELL DERIVED FACTOR 1; STROMAL PRECURSOR ANTIGEN 1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CLONOGENESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; HEART MUSCLE CELL; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; NORMAL HUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, SURFACE; BIOLOGICAL MARKERS; BONE MARROW CELLS; CARDIOVASCULAR DISEASES; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; HUMANS; IMMUNOMAGNETIC SEPARATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MULTIPOTENT STEM CELLS; MYOCYTES, CARDIAC; PARACRINE COMMUNICATION; PLASTICS; REGENERATION; RNA, MESSENGER;

EID: 77950801859     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22081     Document Type: Article

References (51)

1. Alhadlaq A, Mao JJ. 2004. Mesenchymal stem cells: Isolation and therapeutics. Stem Cells Dev 13:436-448. (Pubitemid 39223294)
2. Amado LC, Saliaris AP, Schuleri KH, St John M, Xie JS, Cattaneo S, DurandDJ, Fitton T, Kuang JQ, Stewart G, Lehrke S, Baumgartner WW, Martin BJ, Heldman AW, Hare JM. 2005. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 102:11474-11479. (Pubitemid 41153844)
3. Bensidhoum M, Chapel A, Francois S, Demarquay C, Mazurier C, Fouillard L, Bouchet S, Bertho JM, Gourmelon P, Aigueperse J, Charbord P, Gorin NC, Thierry D, LopezM. 2004. Homing of in vitro expanded Stro-1- or Stro-1+ human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment. Blood 103:3313-3319.
4. Cao R, Brakenhielm E, Pawliuk R,Wariaro D, PostMJ, Wahlberg E, Leboulch P, Cao Y. 2003. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 9:604-613. (Pubitemid 36597108)
5. Castedo E, Castejon R, Monguio E, Ramis S, Montero CG, Serrano-Fiz S, Burgos R, Escudero C, Ugarte J. 2007. Influence of hypothermia on right atrial cardiomyocyte apoptosis in patients undergoing aortic valve replacement. J Cardiothorac Surg 2:7.
6. Chen SL, FangWW,Ye F, Liu YH, Qian J, Shan SJ, Zhang JJ, Chunhua RZ, Liao LM, Lin S, Sun JP. 2004. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94:92-95. (Pubitemid 38813459)
7. Dennis JE, Carbillet JP, Caplan AI, Charbord P. 2002. The STRO-1+ marrow cell population is multipotential. Cells Tissues Organs 170:73-82. (Pubitemid 33151581)
8. Duan HF, Wu CT, Wu DL, Lu Y, Liu HJ, Ha XQ, Zhang QW, Wang H, Jia XX, Wang LS. 2003. Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factor. Mol Ther 8:467-474. (Pubitemid 37161468)
9. Filshie RJ, Zannettino AC, Makrynikola V, Gronthos S, Henniker AJ, Bendall LJ, Gottlieb DJ, Simmons PJ, Bradstock KF. 1998. MUC18, a member of the immunoglobulin superfamily, is expressed on bone marrow fibroblasts and a subset of hematological malignancies. Leukemia 12:414-421. (Pubitemid 28138227)
10. Freyman T, Polin G, Osman H, Crary J, Lu M, Cheng L, Palasis M, Wilensky RL. 2006. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 27:1114-1122.
11. Friedenstein AJ, Chailakhjan RK, Lalykina KS. 1970. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3:393-403.
12. Gnecchi M, Zhang Z, Ni A, Dzau VJ. 2008. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103:1204-1219.
13. Gronthos S, Simmons PJ. 1995. The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. Blood 85:929-940.
14. Gronthos S, Graves SE, Ohta S, Simmons PJ. 1994. The STRO-1-fraction of adult human bone marrow contains the osteogenic precursors. Blood 84:4164-4173. (Pubitemid 24371919)
15. Gronthos S, Simmons PJ, Graves SE, Robey PG. 2001. Integrin-mediated interactions between human bone marrow stromal precursor cells and the extracellular matrix. Bone 28:174-181.
16. Gronthos S, Zannettino AC, Hay SJ, Shi S, Graves SE, Kortesidis A, Simmons PJ. 2003. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 116:1827-1835.
17. Gronthos S, Fitter S, Diamond P, Simmons PJ, Itescu S, Zannettino AC. 2007. A novel monoclonal antibody (STRO-3) identifies an isoform of tissue nonspecific alkaline phosphatase expressed by multipotent bone marrow stromal stem cells. Stem Cells Dev 16:953-963.
18. Gronthos S, McCarty R, Mrozik K, Fitter S, Paton S, Menicanin D, Itescu S, Bartold PM, Xian C, Zannettino AC. 2009. Heat shock protein-90 beta (Hsp90ss) is expressed at the surface of multipotential mesenchymal precursor cells (MPC): Generation of a novel monoclonal antibody, STRO-4, with specificity for MPC from human and ovine tissues. Stem Cells Dev 18:1253-1262.
19. Haider H, Jiang S, Idris NM, Ashraf M. 2008. IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. Circ Res 103:1300-1308.
20. Honczarenko M, Le Y, Swierkowski M, Ghiran I, Glodek AM, Silberstein LE. 2006. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 24:1030-1041.
21. Isenmann S, Cakouros D, Zannettino A, Shi S, Gronthos S. 2007. hTERT transcription is repressed by Cbfa1 in human mesenchymal stem cell populations. J Bone Miner Res 22:897-906.
22. Isenmann S, Arthur A, Zannettino AC, Turner JL, Shi S, Glackin CA, Gronthos S. 2009. TWIST family of basic helix-loop-helix transcription factors mediate human mesenchymal stromal/stem cell growth and commitment. Stem Cells 27:2457-2468.
23. Kasper G, Dankert N, Tuischer J, HoeftM,Gaber T, Glaeser JD, Zander D, Tschirschmann M, Thompson M, Matziolis G, Duda GN. 2007. Mesenchymal stem cells regulate angiogenesis according to their mechanical environment. Stem Cells 25:903-910.
24. Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, Epstein SE. 2004. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94:678-685.
25. Kortesidis A, Zannettino A, Isenmann S, Shi S, Lapidot T, Gronthos S. 2005. Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood 105:3793-3801.
26. Laflamme MA, Murry CE. 2005. Regenerating the heart. Nat Biotechnol 23:845-856.
27. Lee MS, Lowe GN, Strong DD, Wergedal JE, Glackin CA. 1999. TWIST, a basic helix-loop-helix transcription factor, can regulate the human osteogenic lineage. J Cell Biochem 75:566-577.
28. Lee MS, Lowe G, Flanagan S, Kuchler K, Glackin CA. 2000. Human Dermo-1 has attributes similar to twist in early bone development. Bone 27:591-602.
29. Letchford J, Cardwell AM, Stewart K, Coogans KK, Cox JP, Lee M, Beresford JN, Perry MJ, Welham MJ. 2006. Isolation of C15: A novel antibody generated by phage display against mesenchymal stem cell-enriched fractions of adult human marrow. J Immunol Methods 308:124-137.
30. Linke A, Muller P, Nurzynska D, Casarsa C, Torella D, Nascimbene A, Castaldo C, Cascapera S, Bohm M, Quaini F, Urbanek K, Leri A, Hintze TH, Kajstura J, Anversa P. 2005. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci USA 102:8966-8971.
31. Martens TP, See F, Schuster MD, Sondermeijer HP, Hefti MM, ZannettinoA, Gronthos S, Seki T, Itescu S. 2006. Mesenchymal lineage precursor cells induce vascular network formation in ischemic myocardium. Nat Clin Pract Cardiovasc Med 3:S18-S22.
32. Martin SK, Dewar AL, Farrugia AN, Horvath N, Gronthos S, To LB, Zannettino AC. 2006. Tumor angiogenesis is associated with plasma levels of stromal-derived factor-1alpha in patients with multiple myeloma. Clin Cancer Res 12:6973-6977.
33. Matsubara T, Kida K, Yamaguchi A, Hata K, Ichida F, Meguro H, Aburatani H, Nishimura R, Yoneda T. 2008. BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation. J Biol Chem 283:29119-29125.
34. Mets T, Verdonk G. 1981. Variations in the stromal cell population of human bone marrow during aging. Mech Ageing Dev 15:41-49. (Pubitemid 11110075)
35. Nakanishi C, Yamagishi M, Yamahara K, Hagino I, Mori H, Sawa Y, Yagihara T, Kitamura S, Nagaya N. 2008. Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells. Biochem Biophys Res Commun 374:11-16.
36. Nasef A, Zhang YZ, Mazurier C, Bouchet S, Bensidhoum M, Francois S, Gorin NC, Lopez M, ThierryD, Fouillard L, Chapel A. 2009. Selected Stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferation. Int J Lab Hematol 31:9-19.
37. Pan B, Farrugia AN, To LB, Findlay DM, Green J, LynchK,Zannettino AC. 2004. The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE). J Bone Miner Res 19:147-154.
38. Pasha Z,Wang Y, Sheikh R, Zhang D, Zhao T, Ashraf M. 2008. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res 77:134-142.
39. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
40. Psaltis PJ, Zannettino AC, Worthley SG, Gronthos S. 2008. Concise review: Mesenchymal stromal cells: Potential for cardiovascular repair. Stem Cells 26:2201-2210.
41. Quirici N, Soligo D, Bossolasco P, Servida F, Lumini C, Deliliers GL. 2002. Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 30:783-791.
42. Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, Saggio I, Tagliafico E, Ferrari S, Robey PG, Riminucci M, Bianco P. 2007. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131:324-336.
43. Shi S, Gronthos S. 2003. Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res 18:696-704.
44. Shi S,Gronthos S, Chen S, Reddi A, Counter CM, Robey PG, Wang CY. 2002. Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression. Nat Biotechnol 20:587-591. (Pubitemid 34595152)
45. Simmons PJ, Torok-Storb B. 1991. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 78:55-62.
46. Simonsen JL, Rosada C, Serakinci N, Justesen J, Stenderup K, Rattan SI, Jensen TG, Kassem M. 2002. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 20:592-596. (Pubitemid 34595153)
47. Stewart K, Monk P, Walsh S, Jefferiss CM, Letchford J, Beresford JN. 2003. STRO-1, HOP-26 (CD63), CD49a and SB-10 (CD166) as markers of primitive human marrow stromal cells and their more differentiated progeny:Acomparative investigation in vitro. Cell Tissue Res 313:281-290. (Pubitemid 37260435)
48. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. 2002. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105:93-98. (Pubitemid 34049148)
49. UrbanekK, RotaM,Cascapera S, Bearzi C, Nascimbene A, De Angelis A, Hosoda T, Chimenti S, Baker M, Limana F, Nurzynska D, Torella D, Rotatori F, Rastaldo R, Musso E, Quaini F, Leri A, Kajstura J, Anversa P. 2005. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res 97:663-673.
50. Zannettino AC, Paton S, Kortesidis A, Khor F, Itescu S, Gronthos S. 2007. Human mulipotential mesenchymal/stromal stem cells are derived from a discrete subpopulation of STRO-1bright/CD34/CD45(-)/glycophorin-A-bone marrow cells. Haematologica 92:1707-1708. (Pubitemid 350248254)
51. Zhang M, MalN, Kiedrowski M, Chacko M, Askari AT, Popovic ZB, Koc ON, Penn MS. 2007. SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J 21:3197-3207. (Pubitemid 47565538)